2020
DOI: 10.1371/journal.pone.0235121
|View full text |Cite
|
Sign up to set email alerts
|

Anthropometric indices and cut-off points in the diagnosis of metabolic disorders

Abstract: Identifying metabolic disorders at the earliest phase of their development allows for an early intervention and the prevention of serious consequences of diseases. However, it is difficult to determine which of the anthropometric indices of obesity is the best tool for diagnosing metabolic disorders. The aims of this study were to evaluate the usefulness of selected anthropometric indices and to determine optimal cutoff points for the identification of single metabolic disorders that are components of metaboli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
33
2
10

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(56 citation statements)
references
References 51 publications
11
33
2
10
Order By: Relevance
“…Overweight and obesity, typically defined as the body mass index (BMI) of ≥25 kg/m 2 and ≥30 kg/m 2 , respectively, significantly increase the probability of metabolic disorders including MetS and are major risk factors for CVD and T2DM [ 1 , 2 , 3 , 49 , 50 ]. For the BMI, the optimal cut-off point for the identification of metabolic disorders in the European population is 27.2 kg/m 2 [ 51 ]. The waist circumference measurement is recommended for those with BMI of 25 to 34.9 kg/m 2 to provide additional information on CVD risk; however, if BMI is >30 kg/m 2 , central obesity can be assumed and waist circumference does not need to be measured [ 3 , 48 ].…”
Section: Diagnostic Criteria Of Mets and Its Componentsmentioning
confidence: 99%
See 1 more Smart Citation
“…Overweight and obesity, typically defined as the body mass index (BMI) of ≥25 kg/m 2 and ≥30 kg/m 2 , respectively, significantly increase the probability of metabolic disorders including MetS and are major risk factors for CVD and T2DM [ 1 , 2 , 3 , 49 , 50 ]. For the BMI, the optimal cut-off point for the identification of metabolic disorders in the European population is 27.2 kg/m 2 [ 51 ]. The waist circumference measurement is recommended for those with BMI of 25 to 34.9 kg/m 2 to provide additional information on CVD risk; however, if BMI is >30 kg/m 2 , central obesity can be assumed and waist circumference does not need to be measured [ 3 , 48 ].…”
Section: Diagnostic Criteria Of Mets and Its Componentsmentioning
confidence: 99%
“…The waist circumference measurement is recommended for those with BMI of 25 to 34.9 kg/m 2 to provide additional information on CVD risk; however, if BMI is >30 kg/m 2 , central obesity can be assumed and waist circumference does not need to be measured [ 3 , 48 ]. However, owing to the need for screening of individuals with a metabolically obese normal weight, the measuring of waist circumference should be considered when BMI is ≥22.5 kg/m 2 in females and ≥23.8 kg/m 2 in males [ 50 , 51 , 52 ].…”
Section: Diagnostic Criteria Of Mets and Its Componentsmentioning
confidence: 99%
“…Although some previous publications have addressed the association between adiposity and the risk of MetS, some unambiguity remains as to which obesity index is best used to diagnose MetS. 11 BMI is reported to be the most commonly used index to evaluate obesity; 12 Waist to height ratio (WHtR) is reported to be a good predictor of MetS in childhood; 13 And several novel adiposity indices have been constructed recently for screening MetS, including: body roundness index (BRI), 14 a body shape index (ABSI), 15,16 conicity index (CI), Clínica Universidad de Navarra-body adiposity estimator (CUN-BAE), [17][18][19][20] triponderal mass index (TMI), and triglyceride-glucose (TyG) index. [21][22][23][24] The relationships between classic and novel adiposity indices has not been studied in diabetic patients.…”
Section: Introductionmentioning
confidence: 99%
“…Estas correlaciones reafirman la directa relación de la mediciones antropométricas y la asociación con riesgo cardiometabólico (Ashwell & Gibson;Huamán et al, 2017;Díaz et al, 2017). La incorporación de las mediciones morfológicas permiten la identificación precoz de transtornos y patologías componentes del síndrome metabólico, permitiendo mejores intervenciones en los adolescente (Guszek et al, 2020).…”
Section: Discussionunclassified